Lv2
144 积分 2025-11-21 加入
Cryoablation combined with programmed cell death protein 1 (PD-1) inhibitors regulates myeloid-derived suppressor cells (MDSCs) through the JAK2-STAT3-S100A8/A9 axis in mice with Lewis lung carcinoma
16天前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
1个月前
已完结
Microwave ablation combined with third-generation epidermal growth factor receptor-tyrosine kinase inhibitor treatment in EGFR-mutant advanced non-small cell lung cancer
1个月前
已完结
Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer
1个月前
已完结
Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
1个月前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
1个月前
已完结
Osimertinib Plus Durvalumab in Patients With EGFR-Mutated, Advanced NSCLC: A Phase 1b, Open-Label, Multicenter Trial
1个月前
已完结
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
1个月前
已完结
Cryoablation and immunotherapy of cancer
1个月前
已完结
Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways
2个月前
已完结